The top 10 novel drugs for eating and digestive disorders that are currently in development or have recently been approved include: Semaglutide, Ozanimod, Larazotide acetate, Etrasimod, Linaclotide, Tenapanor, Rifamycin SV/MMX, Elobixibat, SGM-1019, AMG 634… Read More »